This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipTrendsBuy This Stock BIOA vs. SION, EOLS, PHAR, DNTH, GHRS, ABCL, ANAB, KALV, ABUS, and BCYCShould you be buying (BIOA) stock or one of its competitors? The main competitors of (BIOA) include Sionna Therapeutics (SION), Evolus (EOLS), Pharming Group (PHAR), Dianthus Therapeutics (DNTH), GH Research (GHRS), AbCellera Biologics (ABCL), AnaptysBio (ANAB), KalVista Pharmaceuticals (KALV), Arbutus Biopharma (ABUS), and Bicycle Therapeutics (BCYC). These companies are all part of the "medical" sector. (BIOA) vs. Sionna Therapeutics Evolus Pharming Group Dianthus Therapeutics GH Research AbCellera Biologics AnaptysBio KalVista Pharmaceuticals Arbutus Biopharma Bicycle Therapeutics Sionna Therapeutics (NASDAQ:SION) and (BIOA) (NYSE:BIOA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking. Does the MarketBeat Community prefer SION or BIOA? (BIOA) received 288 more outperform votes than Sionna Therapeutics when rated by MarketBeat users. However, 75.00% of users gave Sionna Therapeutics an outperform vote while only 72.03% of users gave (BIOA) an outperform vote. CompanyUnderperformOutperformSionna TherapeuticsOutperform Votes375.00% Underperform Votes125.00% (BIOA)Outperform Votes29172.03% Underperform Votes11327.97% Is SION or BIOA more profitable? Company Net Margins Return on Equity Return on Assets Sionna TherapeuticsN/A N/A N/A (BIOA) N/A N/A N/A Do analysts prefer SION or BIOA? Sionna Therapeutics presently has a consensus price target of $38.50, indicating a potential upside of 172.86%. (BIOA) has a consensus price target of $5.67, indicating a potential upside of 42.20%. Given Sionna Therapeutics' stronger consensus rating and higher probable upside, research analysts plainly believe Sionna Therapeutics is more favorable than (BIOA).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00(BIOA) 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75 Does the media favor SION or BIOA? In the previous week, Sionna Therapeutics and Sionna Therapeutics both had 2 articles in the media. Sionna Therapeutics' average media sentiment score of 0.68 beat (BIOA)'s score of 0.00 indicating that Sionna Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sionna Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive (BIOA) 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, SION or BIOA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSionna TherapeuticsN/AN/AN/AN/AN/A(BIOA)N/AN/AN/AN/AN/A SummarySionna Therapeutics beats (BIOA) on 5 of the 6 factors compared between the two stocks. Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOA vs. The Competition Export to ExcelMetric(BIOA)Pharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$161.32M$6.53B$5.39B$19.45BDividend YieldN/A2.65%5.29%3.91%P/E RatioN/A8.7326.9934.73Price / SalesN/A257.87412.1741.78Price / CashN/A65.8538.2517.51Price / BookN/A6.466.844.74Net IncomeN/A$143.21M$3.22B$1.02B (BIOA) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOA(BIOA)N/A$3.99-14.1%$5.67+42.2%+30,915.6%$161.32MN/A0.00N/ASIONSionna TherapeuticsN/A$14.51+8.0%$38.50+165.3%N/A$640.24MN/A0.0035EOLSEvolus3.6757 of 5 stars$9.90+2.1%$23.75+139.9%-26.4%$638.31M$275.46M-10.88170PHARPharming Group2.5531 of 5 stars$9.27+1.5%$30.00+223.6%+13.6%$630.65M$320.71M-35.65280News CoverageShort Interest ↓Gap UpDNTHDianthus Therapeutics1.5138 of 5 stars$19.27-2.1%$53.00+175.0%-19.3%$619.72M$6.52M-7.7180Positive NewsGHRSGH Research1.5603 of 5 stars$11.70+6.6%$30.43+160.1%-12.3%$608.73MN/A-14.8110News CoverageABCLAbCellera Biologics2.8165 of 5 stars$2.02-0.5%$8.33+312.5%-50.0%$602.82M$23.11M-3.31500ANABAnaptysBio2.8165 of 5 stars$20.47+1.2%$35.88+75.3%-10.5%$601.41M$111.87M-3.37100News CoveragePositive NewsAnalyst ForecastKALVKalVista Pharmaceuticals3.8968 of 5 stars$12.07+1.2%$24.83+105.7%+2.9%$600.07MN/A-3.32100News CoveragePositive NewsABUSArbutus Biopharma2.3128 of 5 stars$3.13+1.6%$5.50+75.7%+1.8%$599.48M$6.17M-7.2890BCYCBicycle Therapeutics3.2279 of 5 stars$8.63+6.5%$25.00+189.7%-64.3%$597.66M$25.72M-2.62240 Related Companies and Tools Related Companies Sionna Therapeutics Alternatives Evolus Alternatives Pharming Group Alternatives Dianthus Therapeutics Alternatives GH Research Alternatives AbCellera Biologics Alternatives AnaptysBio Alternatives KalVista Pharmaceuticals Alternatives Arbutus Biopharma Alternatives Bicycle Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIOA) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIOA Stock Free BIOA Stock Alerts